Soligenix(SNGX)
PRINCETON, NJBiotechnology
Focus: Soligenix is a public biotech company focused on oncology, gastroenterology, and immunology using proprietary lipoprotein delivery and small molecule technologies. The company is pre-revenue with a heavily R&D-focused pipeline and minimal commercial infrastructure.
Profile data last refreshed 16m ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Soligenix
AI assessmentNot HiringNo open roles listed right now. Follow Soligenix to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Soligenix's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$119K
Pipeline & Clinical Trials
SGX201
EnteritisClinical Trials (1)
NCT01073384A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
Phase 1/2Help build intelligence for Soligenix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.